Besides ER and HER2 status, pathological factors like tumor size, axillary lymph node involvement, tumor grade and ki-67 level are used for risk stratification; however, some of these are subject to intra- and inter-observer variability. The gene discussed is ERBB2; the disease is neoplasm.